| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.2 |